Professor Andrew Tutt is a consultant clinical oncologist based at the Guy’s Hospital Breast Unit and is a Professor of Oncology at King’s College London School of Medicine.
Prof Tutt trained in clinical oncology at the Royal Marsden Hospital London and in breast cancer research at London’s Institute of Cancer Research, where he gained his PhD in Cancer Biology.
Professor Tutt focuses his clinical practice exclusively on breast oncology and its biological, chemotherapy and radiation therapies. He has a particular research interest in “triple negative” and BRCA1 and BRCA2 associated breast cancers where he has led a number of international clinical trials of drug therapies and is the director of a research program focusing on these areas.
Professor Tutt has published and presented a large number of breast cancer research papers and is an invited speaker and session chair at major European and North American Cancer Medicine conferences. He is a member of the St Gallen International Breast Cancer Consensus Panel that develops international breast cancer treatment guidelines and a member of a UK team testing new techniques in breast radiotherapy.
Professor Tutt offers a range of systemic therapy treatments recommended by international guidelines at LOC at London Bridge Hospital and LOC at 95 Harley Street and the radiotherapy at the Harley Street Clinic Cancer Centre and at the Clinical Oncology departments in the Integrated Cancer Centre at Guy’s and St Thomas’s Hospitals near London Bridge and Waterloo Stations.
